Christian Agboton, MD

Takeda Pharmaceuticals

Poster(s):

• P5371 - Further Validation of the Vedolizumab Clinical Decision Support Tool to Predict the Likelihood of Clinical Remission in Vedolizumab-Treated Patients With Crohn’s Disease
  Tuesday, October 28, 2025

  10:30 AM - 4:00 PM PDT